NAME OF DRUG : BMS_986171
ALSO KNOWN AS : pegbelfermin
LABORATORY : Bristol-MyersSquibb
STATUS AND ADVANCEMENT
Type of drug : PEG-FGF21
Clinical trials advancement : Analysing Results Phase 2a
Estimated time to market : 114 months.
LABORATORY ABSTRACT ON THE DRUG
NOT PROVIDED